Cardiovascular Systems Insider James Flaherty Sells 2,066 Shares (CSII)
Cardiovascular Systems (NASDAQ:CSII) Insider James Flaherty sold 2,066 shares of Cardiovascular Systems stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $20.28, for a total transaction of $41,898.48. Following the completion of the transaction, the insider now directly owns 140,736 shares in the company, valued at approximately $2,854,126. The sale was disclosed in a legal filing with the SEC, which is available at this link.
CSII has been the subject of a number of recent research reports. Analysts at Benchmark Co. initiated coverage on shares of Cardiovascular Systems (NASDAQ:CSII) in a research note to investors on Tuesday, September 10th. They set a “speculative buy” rating and a $26.00 price target on the stock. Separately, analysts at Feltl & Co. upgraded shares of Cardiovascular Systems (NASDAQ:CSII) from a “buy” rating to a “strong-buy” rating in a research note to investors on Thursday, August 8th. They now have a $27.50 price target on the stock, up previously from $19.50. Finally, analysts at Wunderlich initiated coverage on shares of Cardiovascular Systems (NASDAQ:CSII) in a research note to investors on Friday, July 26th. They set a “buy” rating and a $24.00 price target on the stock.
Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Cardiovascular Systems presently has a consensus rating of “Buy” and a consensus target price of $26.30.
Shares of Cardiovascular Systems (NASDAQ:CSII) traded up 0.56% on Monday, hitting $19.91. 269,166 shares of the company’s stock traded hands. Cardiovascular Systems has a 1-year low of $10.38 and a 1-year high of $22.84. The stock’s 50-day moving average is $20.75 and its 200-day moving average is $19.94. The company’s market cap is $495.9 million.
Cardiovascular Systems (NASDAQ:CSII) last released its earnings data on Wednesday, August 7th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. On average, analysts predict that Cardiovascular Systems will post $-1.15 earnings per share for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.